Skip to main content

FDA approves Cross-Pilot laser support catheter


COLORADO SPRINGS, Colo. The Food and Drug Administration has given approval for a laser support catheter.

The Spectranetics Corp. announced Tuesday that the launch of the Cross-Pilot Laser Support Catheter will begin early next year in the United States, Canada and Europe.

The Cross-Pilot is meant to accompany the 0.9 Turbo Elite Laser Ablation Catheter and designed to provide additional support for reaching distal lesions. The braid-reinforced catheter construction and hydrophilic coating allow for better pushability through distal vessels, and the angled tip allows for quicker access to branched anatomy. Spectranetics offers it in 125 cm length and straight with angled tip configurations.

“We are pleased to receive FDA clearance for another important product,” Spectranetics chairman, president and chief executive officer Emile Geisenheimer said in a statement. “The Cross-Pilot product line and the Quick-Cross Extreme product line, which was approved by the FDA last week, will expand our support catheter product offering to the benefit of our physician customers and their patients.”

This ad will auto-close in 10 seconds